The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM, Khair K, Hann I, Liesner R
Br J Haematol 2003;121(3):477-481.
Review by Aldouri M
The interaction between platelets and factor VII/VIIa.
Lau HKF
Transfus Apheresis Sci 2003;28(3):279-283.
Review by Aldouri M
Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
Hardy JF
Can J Anaesth 2002;49(10):S4-S6.
Review by
Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.
Perez R, Martinez ML, Pinero A, Sosa R
Haemophilia 2002;8(6):822-825.
Review by Aldouri M
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MMW, Goede-Bolder ADE, et al.
Haemophilia 2002;8(5):649-656.
Review by M. Aldouri
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Macaitis JM, Hoots K
J Trauma 2002;53(2):252-257.
Review by Aldouri M
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
O’Connell N, McMahon C, Smith J, et al.
Br J Haematol 2002;116(3):632-635.
Review by Aldouri M
Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
O’Connell N, Chen J, Byrne M, OShea E, Smyth H, Smith OP
Br J Haematol 2002;116(3):645-648.
Review by
Potential role for rFVIIa in transfusion medicine.
Hedner U, Erhardtsen E
Transfusion 2002;42(1):114-124.
Review by Aldouri M
Use of recombinant factor VII in hepatology.
Romero Castro R, Barroso Relinque N, Caunedo Alvarez AC, et al.
Rev Esp Enferm Dig 2001;93(10):664-668.
Review by
A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
Chuansumrit A, Sri-Udomporn N, Srimuninnimit V, Juntarukha R
Haemophilia 2001;7(5):532-534.
Review by M. Aldouri
Use of recombinant factor VIIa in hereditary bleeding disorders.
Poon MC
Curr Opin Hematol 2001;8(5):312-318.
Review by M. Aldouri
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D
Bone Marrow Transplant 2001;28(4):405-407.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659